Media coverage
2Media coverage
Title Castle Creek Pharmaceuticals Announces First Patient Enrolled in DELIVERS Study of Diacerein 1% Ointment for Epidermolysis Bullosa Simplex; International randomized, double-blind, parallel group Phase 2/3 clinical trial to evaluate safety and efficacy of Media name/outlet PR Newswire Country United States Date 6/5/17 Persons John C Browning Title Castle Creek Pharmaceuticals Announces First Patient Enrolled in DELIVERS Study of Diacerein 1% Ointment for Epidermolysis Bullosa Simplex; International randomized, double-blind, parallel group Phase 2/3 clinical trial to evaluate safety and efficacy of Media name/outlet PR Newswire Country United States Date 6/5/17 Persons John C Browning